# EDGAR Filing Document

**Accession Number:** 0001404123
**File Stem:** 0001193125-23-044913
**Filing Date:** 2023-2
**Character Count:** 7631
**Document Hash:** 2e265cc50f1dfe40672df479da4aff3a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-044913.hdr.sgml**: 20230222

**ACCESSION NUMBER**: 0001193125-23-044913

**CONFORMED SUBMISSION TYPE**: POSASR

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230222

**DATE AS OF CHANGE**: 20230222

**EFFECTIVENESS DATE**: 20230222

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** 1Life Healthcare Inc
- **CENTRAL INDEX KEY:** 0001404123
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **IRS NUMBER:** 760707204
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** POSASR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-254415
- **FILM NUMBER:** 23654125

**BUSINESS ADDRESS:**
- **STREET 1:** ONE EMBARCADERO CENTER, SUITE 1900
- **CITY:** San Francisco
- **STATE:** CA
- **ZIP:** 94111
- **BUSINESS PHONE:** (415) 814-0927

**MAIL ADDRESS:**
- **STREET 1:** ONE EMBARCADERO CENTER, SUITE 1900
- **CITY:** San Francisco
- **STATE:** CA
- **ZIP:** 94111

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 1life Healthcare Inc
- **DATE OF NAME CHANGE:** 20070621

**As filed with the Securities and Exchange Commission on February 22, 2023** 

**Registration No. 333-254415** 

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

------

**POST-EFFECTIVE AMENDMENT NO. 1** 

**TO** 

**FORM S-3** 

**REGISTRATION STATEMENT NO. 333-254415** 

***UNDER***

***THE SECURITIES ACT OF 1933***

------

## 1Life Healthcare, Inc.
**(Exact name of registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| **Delaware** | **76-0707204** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S Employer**<br> **Identification Number)** |

---

**One Embarcadero Center, Suite 1900** 

**San Francisco, CA 94111** 

**(415) 814-0927** 

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

------

**Amir Dan Rubin** 

**Chief Executive Officer and President** 

**1Life Healthcare, Inc.** 

**One Embarcadero Center, Suite 1900** 

**San Francisco, CA 94111** 

**(415) 814-0927** 

**(Name, address, including zip code, and telephone number, including area code, of agent for service)** 

------

***Copies to:***

**Christodoulos Kaoutzanis** 

**Paul, Weiss, Rifkind, Wharton & Garrison LLP** 

**1285 Avenue of the Americas** 

**New York, NY 10019** 

**(212) 373-3445** 

------

**Approximate date of commencement of proposed sale to the public:** Not applicable. Removal from registration of securities that were not sold pursuant to the above referenced registration statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☐

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☒

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**DEREGISTRATION OF SECURITIES** 

This Post-Effective Amendment relates to the following Registration Statement on Form S-3 (the "Registration Statement") filed by 1Life Healthcare, Inc., a Delaware corporation (the "Registrant" or the "Company") with the Securities and Exchange Commission (the "SEC"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Registration Statement on Form S-3 (File No. 333-254415) filed with the SEC on March 17, 2021, registering an indeterminate number of shares of common stock, par value $0.001 per share, shares of preferred stock, par value $0.001 per share,
debt securities, and warrants.

On February 22, 2023, pursuant to the Agreement and Plan of Merger, dated as of July 20, 2022 (the "Merger Agreement"), by and among the Company, Amazon.com, Inc., a Delaware corporation ("Parent"), and Negroni Merger Sub, Inc., a Delaware corporation ("Merger Sub"), the Company became a wholly owned subsidiary of Parent.

As a result of the consummation of the transactions contemplated by the Merger Agreement, the Registrant has terminated all offerings of its securities pursuant to the Registration Statement. In accordance with an undertaking made by the Registrant in the Registration Statement to remove from registration by means of a post-effective amendment any securities which remain unsold at the termination of the offering, the Registrant hereby removes and withdraws from registration any and all securities of the Registrant registered pursuant to the Registration Statement that remain unsold or otherwise unissued as of the date hereof. The Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities, and the Registrant hereby terminates the effectiveness of the Registration Statement.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment to the Registration Statement on Form S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Francisco, State of California on February 22, 2023.

---

| | |
|:---|:---|
| 1LIFE HEALTHCARE, INC. | 1LIFE HEALTHCARE, INC. |
| By: | /s/ Amir Dan Rubin |
|  | Amir Dan Rubin<br> Chief Executive Officer and President |

---

Pursuant to Rule 478 under the Securities Act of 1933, as amended, no other person is required to sign this Post-Effective Amendment No. 1 to the Registration Statement.